Functional independency between catalytic activity and subcellular targeting of polo-like kinase-1

被引:1
|
作者
Ji, Jae-Hoon [1 ,2 ]
Jang, Young-Joo [1 ]
机构
[1] Dankook Univ, Sch Dent, Biochem Lab, Cheonan Si 330714, Chungnam, South Korea
[2] Dankook Univ, Dept Mol Biol, Yongin, Gyeonggi Do, South Korea
关键词
cell cycle; mitosis; polo-like kinase-1; polo-box; ectopic expression;
D O I
10.4161/cc.7.11.5897
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
The mammalian polo- like kinase-1 (Plk1) plays key role in the progression of the M-phase. As cells enter the M-phase, Plk1 is phosphorylated by an upstream kinase on Thr-210 in N-terminal region, which is essential for Plk1 activation. In addition to catalytic activation, the subcellular localization is also an important task for Plk1, and the C-terminal polo- boxes are responsible for Plk1 targeting. Although both catalytic activation and targeting might be essential and work concurrently, it is still unclear which process precedes the other in mitotic progression, and which is more essential for the function of Plk1 through the M-phase. In order to investigate this mechanism, this study introduced several point mutations in the catalytic and polo- box domains, and overexpressed these constructs in HeLa cells. Although the cellular effects by ectopic expression were different in the cells containing various Plk1 constructs, phosphorylation itself, not the catalytic activity, was found to be important for the progression of the M-phase. Plk1 phosphorylation was also responsible for targeting by polobox, and compensated for the polo- box mutation. These results suggested that Plk1 is phosphorylated in the starting M-phase, and this phosphorylation induces polo- box targeting through a possible conformational change. In this situation, catalytic activation does not appear to be a critical factor for the function of Plk1.
引用
收藏
页码:1597 / 1603
页数:7
相关论文
共 50 条
  • [1] Phosphorylation of TCTP as a Marker for Polo-like Kinase-1 Activity In Vivo
    Cucchi, Ulisse
    Gianellini, Laura M.
    De Ponti, Anna
    Sola, Francesco
    Alzani, Rachele
    Patton, Veronica
    Pezzoni, Alice
    Troiani, Sonia
    Saccardo, Maria B.
    Rizzi, Simona
    Giorgini, Maria L.
    Cappella, Paolo
    Berta, Italo
    Valsasina, Barbara
    ANTICANCER RESEARCH, 2010, 30 (12) : 4973 - 4985
  • [2] Polo-like kinase-1 in DNA damage response
    Hyun, Sun-Yi
    Hwan, Hyo-In
    Jang, Young-Joo
    BMB REPORTS, 2014, 47 (05) : 249 - 255
  • [3] Getting in and out of mitosis with Polo-like kinase-1
    Marcel A T M van Vugt
    René H Medema
    Oncogene, 2005, 24 : 2844 - 2859
  • [4] Getting in and out of mitosis with Polo-like kinase-1
    van Vugt, MATM
    Medema, RH
    ONCOGENE, 2005, 24 (17) : 2844 - 2859
  • [5] A Perspective on Polo-Like Kinase-1 Inhibition for the Treatment of Rhabdomyosarcomas
    Gatz, Susanne A.
    Aladowicz, Ewa
    Casanova, Michela
    Chisholm, Julia C.
    Kearns, Pamela R.
    Fulda, Simone
    Geoerger, Birgit
    Schaefer, Beat W.
    Shipley, Janet M.
    FRONTIERS IN ONCOLOGY, 2019, 9
  • [6] Switching Polo-like kinase-1 on and off in time and space
    Bruinsma, Wytse
    Raaijmakers, Jonne A.
    Medema, Rene H.
    TRENDS IN BIOCHEMICAL SCIENCES, 2012, 37 (12) : 534 - 542
  • [7] Polo-like kinase-1 is a target of the DNA damage checkpoint
    Smits, VAJ
    Klompmaker, R
    Arnaud, L
    Rijksen, G
    Nigg, EA
    Medema, RH
    NATURE CELL BIOLOGY, 2000, 2 (09) : 672 - 676
  • [8] Increased Human Polo-Like Kinase-1 Expression in Gliomas
    K. Dietzmann
    E. Kirches
    P. von Bossanyi
    K. Jachau
    Ch. Mawrin
    Journal of Neuro-Oncology, 2001, 53 : 1 - 11
  • [9] Polo-like kinase-1 is a target of the DNA damage checkpoint
    Veronique A. J. Smits
    Rob Klompmaker
    Lionel Arnaud
    Gert Rijksen
    Erich A. Nigg
    René H. Medema
    Nature Cell Biology, 2000, 2 : 672 - 676
  • [10] Increased human polo-like kinase-1 expression in gliomas
    Dietzmann, K
    Kirches, E
    von Bossanyi, P
    Jachau, K
    Mawrin, C
    JOURNAL OF NEURO-ONCOLOGY, 2001, 53 (01) : 1 - 11